Effects of Sorafenib on C-Terminally Truncated Androgen Receptor Variants in Human Prostate Cancer Cells

Erstveröffentlichung
2012Authors
Zengerling, Friedemann
Streicher, Wolfgang
Schrader, Andres J.
Schrader, Mark
Nitzsche, Bianca
Wissenschaftlicher Artikel
Published in
International Journal of Molecular Sciences ; 13 (2012), 9. - S. 11530-11542. - eISSN 1422-0067
Link to publication
https://dx.doi.org/10.3390/ijms130911530Faculties
Fakultät für NaturwissenschaftenInstitutions
UKU. Klinik für Urologie und KinderurologieInstitut für Molekulare Endokrinologie der Tiere
Subject headings
[Free subject headings]: sorafenib | truncated androgen receptor variants | castration resistant prostate cancer | PHASE-II | INHIBITION | GROWTH | MECHANISM | APOPTOSIS | MUTATION | PHOSPHORYLATION | STEROIDOGENESIS | PROLIFERATION | CHEMOTHERAPY[DDC subject group]: DDC 540 / Chemistry & allied sciences | DDC 570 / Life sciences